Following R3ALM Strategic Acquisition, Vystar Executes Sale of Remaining Vytex Inventory
Vystar advances its pivot to the R3ALM tokenization ecosystem by exiting Vytex inventory and marketing RXAIR assets valued above $2 million.
Rhea-AI Summary
Vystar (VYST) completed the sale of substantially all remaining inventory tied to its Vytex business as part of a strategic shift toward its recently acquired R3ALM Financial Ecosystem.
CEO Jamie Rotman said the Vytex sale covered 1,395 individual pieces, including toppers, beds, pillows and covers, and confirmed that all of this inventory has left the company’s warehouse. The move is described as further streamlining legacy operations so resources can be concentrated on developing R3ALM, a compliance-focused ecosystem for tokenized real-world assets, private-market transactions, digital capital formation and related financial applications.
Vystar is also in discussions with several interested parties on a potential sale of its RXAIR inventory and related assets, which the company currently estimates to be worth more than $2 million. These RXAIR assets include production tooling and two FDA Class II medical devices. Vystar plans to provide additional updates on its RXAIR and Vytex divestiture efforts, while maintaining that its primary strategic focus is the advancement of the R3ALM ecosystem.
Positive
- Vytex inventory exit completed: 1,395 pieces sold and removed from warehouse
- R3ALM ecosystem designated as Vystar’s primary strategic focus
- RXAIR assets marketed with company-estimated value above $2 million, including tooling and two FDA Class II devices
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST) today announced the completion of a sale of substantially all remaining inventory associated with its Vytex business as the Company continues its strategic repositioning following its acquisition of the R3ALM Financial Ecosystem.
Vystar CEO Jamie Rotman stated, “I have completed a sale of substantially all remaining Vytex inventory, consisting of 1,395 individual pieces, including toppers, beds, pillows and covers. All of the inventory has now left our warehouse.”
The transaction represents another step in Vystar’s efforts to streamline its legacy operations and concentrate resources on the development of the R3ALM ecosystem.
Vystar’s Strategic Focus on R3ALM
Vystar is increasingly focused on R3ALM and its potential to participate in the rapidly developing market for tokenized real-world assets and on-chain financial instruments.
The tokenization sector remains in its early stages, while major financial institutions and consulting firms have projected substantial long-term growth as traditional financial assets—including investment funds, U.S. Treasuries, private credit and real estate—are increasingly represented on blockchain-based infrastructure.
R3ALM is being developed as a compliance-focused ecosystem designed to support tokenization, private-market transactions, digital capital formation and related financial applications. The platform is also intended to address opportunities associated with the global crowdfunding and private-capital markets.
“R3ALM represents a transformational evolution for Vystar,” said Jamie Rotman, CEO of Vystar. “This ecosystem positions us at the intersection of private markets, tokenization and AI—areas where we believe significant innovation in the future of finance will occur.”
RXAIR Strategic Divestiture
Vystar is also engaged with several interested parties regarding a potential sale of its RXAIR inventory and related assets. The assets are currently estimated by the Company to have a value in excess of
The RXAIR assets include production tooling and two FDA Class II medical devices, providing a potential strategic opportunity for an industry-specific buyer seeking to acquire established product lines, manufacturing capabilities and related assets.
Vystar expects to provide additional updates regarding its strategic milestones and developments related to its RXAIR and Vytex divestiture efforts as appropriate.
The Company’s primary strategic focus continues to be the development and advancement of the R3ALM ecosystem.
About Vystar Corporation
Vystar Corporation is focused on identifying and advancing strategic opportunities that can enhance shareholder value and expand the Company’s participation in high-potential innovation markets. Through this proposed transaction with R3alm, Vystar is seeking to establish a meaningful position in the evolution of digital finance, tokenized assets, intelligent trust systems and modern capital markets infrastructure.
About R3alm
R3alm is building a compliance-focused AI and Web3 ecosystem designed to connect capital formation, tokenized assets, investor access, digital finance infrastructure, trust systems and intelligent automation. Its broader platform vision is intended to support both enterprise and consumer participation in the next generation of financial markets.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. Such statements include, but are not limited to, statements regarding the proposed transaction, anticipated strategic benefits, the development of the R3alm ecosystem, the proposed R3EQ equity token, future product and platform capabilities, capital markets opportunities, market adoption, regulatory positioning and expected long-term value creation. These forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Vystar undertakes no obligation to update any forward-looking statements except as required by law.
Important Information
This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities, tokens or investment products in any jurisdiction. Any such offering, if made, will be made only pursuant to definitive offering materials and in compliance with applicable law.
Investor / Media Contact
Vystar Corporation
Investor Relations: https://vystarcorp.com/investor-relations
Company websites: https://r3alm.com
Media & Investors: Jamie Rotman - jrotman@vytex.com
FAQ
What exactly did Vystar sell from its Vytex business?
The Vytex transaction covered 1,395 individual pieces of inventory, including toppers, beds, pillows and covers. Jamie Rotman stated that all of this inventory has now left Vystar’s warehouse, representing substantially all remaining Vytex-related inventory.
What is Vystar’s strategic objective with the R3ALM ecosystem?
Vystar is redirecting its strategic focus to the development of R3ALM, described as a compliance-focused ecosystem intended to support tokenization of real-world assets, private-market transactions, digital capital formation and related financial applications. The company also cites opportunities in global crowdfunding and private-capital markets, and characterizes R3ALM as placing Vystar at the intersection of private markets, tokenization and AI.
What assets are included in the potential RXAIR sale and how are they valued?
The RXAIR package being discussed with interested parties includes inventory, production tooling and two FDA Class II medical devices. Vystar currently estimates the value of these RXAIR assets to be in excess of $2 million, and describes them as a potential strategic opportunity for an industry-specific buyer seeking established product lines and manufacturing capabilities.